ALPHARETTA, GA., - EndoChoice, Inc. announced today that it has acquired Pathworks Anatomic Pathology Laboratory. Founded in 1989, Pathworks is a College of American Pathologists (CAP) accredited national reference laboratory located in Atlanta, GA. Robert Smith, MD, founder of the laboratory, will assume the Medical Director position of EndoChoice Pathology, a wholly-owned subsidiary of EndoChoice, Inc.
"We are excited to leverage our GI expertise and join the EndoChoice team. For pathology services, our subspecialty focus ensures quality results. With its complete focus on the GI community, EndoChoice is a natural fit for our organization," said Dr. Smith.
The EndoChoice GI Diagnostics Division offers the broadest range of diagnostic products and services in the industry, including anatomic pathology services, immunochemical fecal occult blood tests (FIT), H. pylori tests, and the first gene expression tests for inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS). EndoChoice Pathology provides high-quality lab services through its gastrointestinal specific and subspecialty- trained pathologists.
"Our unique ability to provide a comprehensive suite of diagnostic products and services is important to our customers and their patients. This successful acquisition further expands our ability to deliver outstanding clinical services to our physician clients across the nation," said Mark Gilreath, CEO of EndoChoice.
About EndoChoice, Inc.
EndoChoice designs, manufactures and markets innovative solutions for professionals in gastrointestinal endoscopy worldwide. Its diverse portfolio of high-quality equipment, devices, supplies and services uniquely positions EndoChoice as a leading resource for GI professionals. The company strives to exceed its customers' expectations through its superior products, exemplary customer care, knowledgeable sales force, and easy online ordering. For more information, visit www.endochoice.com.